Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)

NACompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

October 31, 2016

Conditions
DepressionDepressive DisorderDepressive Disorder, Treatment-resistantDepressive Disorder, Major
Interventions
DEVICE

LFMS

Low field magnetic stimulation (1 kilohertz oscillating magnetic field) will be administered using a portable tabletop device capable of generating time-varying electromagnetic fields of LFMS. For sham therapy, the device will be on; however, no magnetic field stimulation will be delivered.

Trial Locations (12)

30005

Institute for Advanced Medical Research, Alpharetta

30328

Radiant Research, Atlanta

32256

CNS Healthcare, Jacksonville

32607

Sarkis Clinical Trials, Gainesville

33319

Segal Institute, Lauderhill

44718

Neurobehavioral-Clinical Research, Canton

45417

Midwest Clinical, Dayton

75231

Future Search Trials, Dallas

91945

Synergy Escondido, Lemon Grove

92845

CNS Trials, Garden Grove

94612

Pacific Trials Partners, Oakland

98007

Northwest Clinical Research Center, Bellevue

All Listed Sponsors
lead

Tal Medical, Inc.

INDUSTRY

NCT02452892 - Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD) | Biotech Hunter | Biotech Hunter